TheTARC/sICAM5 ratio in patient plasma is a candidate biomarker for drug resistant epilepsy

Frontiers in Neurology

Volumn 3 JAN, Issue , 2013, Pages

  Pollard, John R ^a   Eidelman, Ofer ^b   Mueller, Gregory P ^b   Dalgard, Clifton L ^b   Crino, Peter B ^a   Anderson, Christopher T ^a   Brand, Elizabeth J ^a   Burakgazi, Evren ^c   Ivaturi, Sai K ^a   Pollard, Harvey B ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c Department of Anesthesiology   (United States)

Author keywords

Biomarkers; Epilepsy; Neuroinflammation

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CLONAZEPAM; CYTOKINE; ETIRACETAM; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 8; LORAZEPAM; OXCARBAZEPINE; PHENYTOIN; PREGABALIN; TELENCEPHALIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TOPIRAMATE; UNCLASSIFIED DRUG; ZONISAMIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; FEMALE; HUMAN; MALE; MONITORING; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; STUDENT T TEST;

EID: 84874563005     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2012.00181     Document Type: Article

References (46)

1. Abbott, R. J., Browning, M. C., and Davidson, D. L. (1980). Serum pro-lactin and cortisol concentrations after grand mal seizures. J. Neurol. Neurosurg. Psychiatr. 43, 163-167.
2. Alapirtti, T., Rinta, S., Hulkkonen, J., Makinen, R., Keranen, T., and Peltola, J. (2009). Interleukin-6, interleukin-1 receptor antagonist and interleukin-1beta production in patients with focal epilepsy: a video-EEG study. J. Neurol. Sci. 280, 94-97.
3. Alapirtti, T., Waris, M., Fallah, M., Soilu-Hanninen, M., Maki-nen, R., Kharazmi, E., et al. (2012). C-reactive protein and seizures in focal epilepsy: a video-electroencephalographic study. Epilepsia 53, 790-796.
4. Arii, N., Mizuguchi, M., Mori, K., and Takashima, S. (1999). Develop-ment of telencephalin in the human cerebrum. Microsc. Res. Tech. 46, 18-23.
5. Aronica, E., and Crino, P. B. (2011). Inflammation in epilepsy: clinical observations. Epilepsia 52(Suppl. 3), 26-32.
6. Balosso, S., Maroso, M., Sanchez-Alavez, M., Ravizza, T., Frasca, A., Bartfai, T., et al. (2008). A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain 131, 3256-3265.
7. Bauer, S., Cepok, S., Todorova-Rudolph, A., Nowak, M., Koller, M., Lorenz, R., et al. (2009). Etiology and site of temporal lobe epilepsy influence postictal cytokine release. Epilepsy Res. 86, 82-88.
8. Beghi, E., and Shorvon, S. (2011). Antiepileptic drugs and the immune system. Epilepsia 52(Suppl. 3), 40-44.
9. Benson, D. L., Yoshihara, Y., and Mori, K. (1998). Polarized distribution and cell type-specific localization of telencephalin, an intercellular adhe-sion molecule. J. Neurosci. Res. 52, 43-53.
10. Conant, K., Wang, Y., Szklarczyk, A., Dudak, A., Mattson, M. P., and Lim, S. T. (2010). Matrix metalloproteinase-dependent shed-ding of intercellular adhesion molecule-5 occurs with long-term potentiation. Neuroscience 166, 508-521.
11. Engel, J. Jr. (2001). A proposed diag-nostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE task force on classification and terminology. Epilepsia 42, 796-803.
12. Engel, J. Jr. (2011). Biomarkers in epilepsy: introduction. Biomark. Med. 5, 537-544.
13. England, M. J., Liverman, C. T., Schultz, A. M., Strawbridge, L. M., Commit-tee on the Public Health Dimen-sions of the Epilepsies, Board on Health Sciences Policy, and Insti-tute of Medicine (eds). (2012). Epilepsy Across the Spectrum: Pro-moting Health and Understanding (Washington: The National Archives Press).
14. Fabene, P. F., Navarro Mora, G., Mar-tinello, M., Rossi, B., Merigo, F., Ottoboni, L., et al. (2008). A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat. Med. 14, 1377-1383.
15. Furutani, Y., Matsuno, H., Kawasaki, M., Sasaki, T., Mori, K., and Yoshi-hara, Y. (2007). Interaction between telencephalin and ERM family pro-teins mediates dendritic filopo-dia formation. J. Neurosci. 27, 8866-8876.
16. Galic, M. A., Riazi, K., and Pittman, Q. J. (2012). Cytokines and brain excitability. Front. Neuroendocrinol 33, 116-125.
17. Hauser, W. A., Annegers, J. F., and Kurland, L. T. (1993). Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 34, 453-468.
18. Imai, T., Baba, M., Nishimura, M., Kak-Izaki, M., Takagi, S., and Yoshie, O. (1997). The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J. Biol. Chem. 272, 15036-15042.
19. Imai, T., Yoshida, T., Baba, M., Nishimura, M., Kakizaki, M., and Yoshie, O. (1996). Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J. Biol. Chem. 271, 21514-21521.
20. Iyer, A., Zurolo, E., Spliet, W. G., Van Rijen,P. C.,Baayen,J. C.,Gorter,J.A., et al. (2010). Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia 51, 1763-1773.
21. Jansen, J. F., Vlooswijk, M. C., De Baets, M. H., De Krom, M. C., Rieckmann, P., Backes, W. H., et al. (2008). Cognitive fMRI and sol-uble telencephalin assessment in patients with localization-related epilepsy. Acta Neurol. Scand. 118, 232-239.
22. Kipnis, J., Cohen, H., Cardon, M., Ziv, Y., and Schwartz, M. (2004). T cell deficiency leads to cognitive dysfunction: implications for ther-apeutic vaccination for schizophre-nia and other psychiatric conditions. Proc. Natl. Acad. Sci. U.S.A. 101, 8180-8185.
23. Kusterer, K., Bojunga, J., Enghofer, M., Heidenthal, E., Usadel, K. H., Kolb, H., et al. (1998). Soluble ICAM-1 reduces leukocyte adhesion to vascular endothelium in ischemia-reperfusion injury in mice. Am. J. Physiol. 275, G377-G380.
24. Lehtimaki, K. A., Keranen, T., Palmio, J., Makinen, R., Hurme, M., Honkaniemi, J., et al. (2007). Increased plasma levels of cytokines after seizures in localization-related epilepsy. Acta Neurol. Scand. 116, 226-230.
25. Lehtimaki, K. A., Keranen, T., Palmio, J., and Peltola, J. (2010). Levels of IL-1beta and IL-1ra in cerebrospinal fluid of human patients after single and prolonged seizures. Neuroim-munomodulation 17, 19-22.
26. Lindsberg, P. J., Launes, J., Tian, L., Val-imaa, H., Subramanian, V., Siren, J., et al. (2002). Release of soluble ICAM-5, a neuronal adhesion mole-cule, in acute encephalitis. Neurology 58, 446-451.
27. Majoie, H. J., Rijkers, K., Berfelo, M. W., Hulsman, J. A., Myint, A., Schwarz, M., et al. (2010). Vagus nerve stimu-lation in refractory epilepsy: effects on pro-and anti-inflammatory cytokines in peripheral blood. Neu-roimmunomodulation 18, 52-56.
28. Maroso, M., Balosso, S., Ravizza, T., Liu, J., Aronica, E., Iyer, A. M., et al. (2010). Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat. Med. 16, 413-419.
29. Mendez, M. P., Morris, S. B., Wilcoxen, S., Du, M., Monroy, Y. K., Rem-Mer, H., et al. (2008). Disparate mechanisms of sICAM-1 produc-tion in the peripheral lung: con-trast between alveolar epithelial cells and pulmonary microvascu-lar endothelial cells. Am. J. Phys-iol. Lung Cell Mol. Physiol. 294, L807-L814.
30. Mizuno, T., Yoshihara, Y., Inazawa, J., Kagamiyama, H., and Mori, K. (1997). cDNA cloning and chromosomal localization of the human telencephalin and its dis-tinctive interaction with lympho-cyte function-associated antigen-1. J. Biol. Chem. 272, 1156-1163.
31. Mizuno, T., Yoshihara, Y., Kagamiyama, H., Ohsawa, K., Imai, Y., Kohsaka, S., et al. (1999). Neuronal adhesion molecule telencephalin induces rapid cell spreading of microglia. Brain Res. 849, 58-66.
32. Ortinski, P. I., Dong, J., Mungenast, A., Yue, C., Takano, H., Watson, D. J., et al. (2010). Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat. Neurosci. 13, 584-591.
33. Palmio, J., Keranen, T., Alapirtti, T., Hulkkonen, J., Makinen, R., Holm, P., et al. (2008). Elevated serum neuron-specific enolase in patients with temporal lobe epilepsy: a video-EEG study. Epilepsy Res. 81,155-160.
34. Peltola, J., Palmio, J., Korhonen, L., Suhonen, J., Miettinen, A., Hurme, M., et al. (2000). Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures. Epilepsy Res. 41, 205-211.
35. Rieckmann, P., Turner, T., Kligannon, P., and Steinhoff, B. J. (1998). Telencephalin as an indicator for temporal-lobe dysfunction. Lancet 352, 370-371.
36. Schwartz, M., and Kipnis, J. (2011). A conceptual revolution in the rela-tionships between the brain and immunity. Brain Behav. Immun. 25, 817-819.
37. Srivastava, M., Eidelman, O., Torosyan, Y., Jozwik, C., Mannon, R. B., and Pollard, H. B. (2011). Elevated expression levels of ANXA11, inte-grins beta3 and alpha3, and TNF-alpha contribute to a candidate pro-teomic signature in urine for kidney allograft rejection. Proteomics. Clin. Appl. 5, 311-321.
38. Tian, L., Kilgannon, P., Yoshihara, Y., Mori, K., Gallatin, W. M., Carpen, O., et al. (2000). Binding of T lym-phocytes to hippocampal neurons through ICAM-5 (telencephalin) and characterization of its inter-action with the leukocyte integrin CD11a/CD18. Eur. J. Immunol. 30, 810-818.
39. Tian, L., Lappalainen, J., Autero, M., Hanninen, S., Rauvala, H., and Gahmberg, C. G. (2008). Shedded neuronal ICAM-5 suppresses T-cell activation. Blood 111, 3615-3625.
40. Tian, L., Stefanidakis, M., Ning, L., Van Lint, P., Nyman-Huttunen, H., Libert, C., et al. (2007). Activation of NMDA receptors promotes den-dritic spine development through MMP-mediated ICAM-5 cleavage. J. Cell Biol. 178, 687-700.
41. Vezzani, A., and Friedman, A. (2011). Brain inflammation as a bio-marker in epilepsy. Biomark. Med. 5, 607-614.
42. Vezzani, A., and Granata, T. (2005). Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46, 1724-1743.
43. Vezzani, A., Ravizza, T., Balosso, S., and Aronica, E. (2008). Glia as a source of cytokines: implica-tions for neuronal excitability and survival. Epilepsia 49(Suppl. 2), 24-32.
44. Yoshihara, Y., and Mori, K. (1994). Telencephalin: a neuronal area code molecule? Neurosci. Res. 21, 119-124.
45. Yoshihara, Y., Oka, S., Nemoto, Y., Watanabe, Y., Nagata, S., Kagamiyama, H., Mori, K., et al. (1994). An ICAM-related neuronal glycoprotein, telencephalin, with brain segment-specific expression. Neuron 12, 541-553.
46. Ziv, Y., Ron, N., Butovsky, O., Landa, G., Sudai, E., Greenberg, N., et al. (2006). Immune cells contribute to the maintenance of neuroge-nesis and spatial learning abili-ties in adulthood. Nat. Neurosci. 9, 268-275.